Kaisa Health Group Holdings Limited (HKG:0876)
Hong Kong · Delayed Price · Currency is HKD 0.0200
-0.0010 (-4.76%)
Jul 23, 2025, 2:26 PM HKT
HKG:0876 Revenue
In the year 2024, Kaisa Health Group Holdings had annual revenue of 185.36M HKD, down -0.28%. Kaisa Health Group Holdings had revenue of 96.84M in the half year ending December 31, 2024, a decrease of -0.70%.
Revenue
185.36M
Revenue Growth
-0.28%
P/S Ratio
0.57
Revenue / Employee
215.28K
Employees
861
Market Cap
105.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 185.36M | -525.00K | -0.28% |
| Dec 31, 2023 | 185.88M | -5.62M | -2.93% |
| Dec 31, 2022 | 191.50M | -18.13M | -8.65% |
| Dec 31, 2021 | 209.63M | 25.82M | 14.04% |
| Dec 31, 2020 | 183.81M | -67.81M | -26.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |